Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

NCT02064439 ·Status: COMPLETED ·Phase: PHASE3

Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication

NCT01805544 ·Status: COMPLETED

Effectiveness and Safety of Rivaroxaban Used in Extended Anticoagulation for Pulmonary Embolism Patients

NCT04527042 ·Status: UNKNOWN

Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

NCT02627053 ·Status: UNKNOWN ·Phase: PHASE3

Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.

NCT02704598 ·Status: UNKNOWN ·Phase: NA

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

NCT01619007 ·Status: COMPLETED

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

NCT02504216 ·Status: COMPLETED ·Phase: PHASE3

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

NCT02111564 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy

NCT02210819 ·Status: COMPLETED

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

NCT01780987 ·Status: COMPLETED ·Phase: PHASE3

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491 ·Status: COMPLETED

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

NCT04979780 ·Status: COMPLETED

Follow-up in Rivaroxaban Patients in Setting of Thromboembolism

NCT02248610 ·Status: COMPLETED

Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant

NCT02079584 ·Status: COMPLETED

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

NCT01871194 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

NCT02555878 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

NCT04444804 ·Status: COMPLETED

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

NCT01598051 ·Status: COMPLETED

An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs

NCT07142655 ·Status: COMPLETED

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

NCT02746185 ·Status: COMPLETED ·Phase: PHASE3

Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism

NCT02898051 ·Status: UNKNOWN

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

NCT02742623 ·Status: COMPLETED

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

NCT00571649 ·Status: COMPLETED ·Phase: PHASE3

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

NCT05150938 ·Status: COMPLETED

Risk Factors for Venous Thromboembolism in the Community

NCT00011180 ·Status: COMPLETED